Birgitta-A
Wed Dec 10, 2014, 04:25 AM
Hi All!
Here is a report from ASH about Revlimid for non del5q patients where 27% of the patients responed.
http://www.checkorphan.org/grid/news/treatment/results-from-phase-iii-study-of-revlimid-r-lenalidomide-demonstrating-improved-transfusion-independence-in-patients-with-rare-blood-cancer-non-del-5q-myelodysplastic-syndromes-mds-presented-at-ash
Kind regards
Birgitta-A
Chromosome aberrations -12p and -X. Revlimid + Prednisone July 2013-Nov 2014 with good response one year.
Here is a report from ASH about Revlimid for non del5q patients where 27% of the patients responed.
http://www.checkorphan.org/grid/news/treatment/results-from-phase-iii-study-of-revlimid-r-lenalidomide-demonstrating-improved-transfusion-independence-in-patients-with-rare-blood-cancer-non-del-5q-myelodysplastic-syndromes-mds-presented-at-ash
Kind regards
Birgitta-A
Chromosome aberrations -12p and -X. Revlimid + Prednisone July 2013-Nov 2014 with good response one year.